...
首页> 外文期刊>Clinical and experimental ophthalmology >Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study.
【24h】

Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study.

机译:患有和不患有青光眼的受试者的optineurin(OPTN)基因突变分析:蓝山眼研究。

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background: The optineurin (OPTN) gene has been reported to possess both causal as well as risk-associated alleles for open-angle glaucoma. However, these findings have so far only been reported in family and clinic based studies. The aim of this study was to investigate the spectrum of mutations and gene variants in OPTN that might be present in people with glaucoma from a population-based study, the Blue Mountains Eye Study (BMES). Methods: A total of 108 subjects of Caucasian origin were identified at baseline in the BMES as having open-angle glaucoma. Blood samples were available from 27 of these, of whom 18 had high-tension glaucoma and the remaining nine had normal-tension glaucoma. Ninety-four control subjects were chosen at random from the BMES, who satisfied the criteria of not having glaucoma at baseline and were over age 70 years. The 13 coding exons (exons 4-16 inclusive) and their intron-exon boundaries of OPTN were screened by the use of single-strand conformation polymorphism. Samples exhibiting mobility shifts were di-deoxy nucleotide sequenced. The M98K polymorphism was additionally screened using the restriction enzyme Stu1 in all cases and controls in this study. Results: The M98K risk-associated alteration was identified in 2/18 (11%) subjects with high-tension glaucoma, 0/9 subjects (0%) with normal-tension glaucoma and 3/94 (3.2%) controls. However, association of this variant with disease was not significant (P = 0.2 for each phenotype) for either high-tension glaucoma or normal-tension glaucoma. A novel variant (P556P in exon 16) was found in one subject with open-angle glaucoma and a previously described variant (exon 7) was found in a further subject with open-angle glaucoma and in one control. No other OPTN variants were identified in this study cohort. Conclusions: Cross-sectional analysis from baseline observations of the BMES suggested that the M98K risk-associated allele appeared at a higher prevalence in high-tension glaucoma compared with controls, although this finding was not statistically significant.
机译:摘要背景:据报道,optineurin(OPTN)基因具有开角型青光眼的因果关系以及与风险相关的等位基因。但是,到目前为止,这些发现仅在基于家庭和临床的研究中得到报道。这项研究的目的是调查基于人群的研究蓝山眼研究(BMES)中青光眼患者中可能存在的OPTN突变和基因变异的光谱。方法:在BMES基线时,共鉴定出108名白种人起源的受试者为开角型青光眼。其中有27例血液样本,其中18例患有高血压青光眼,其余9例患有正常青光眼。从BMES中随机选择了94名对照受试者,这些受试者符合基线时无青光眼的标准并且年龄超过70岁。通过使用单链构象多态性筛选了OPTN的13个编码外显子(包括4-16个外显子)及其内含子-外显子边界。对显示出迁移率变化的样品进行二脱氧核苷酸测序。在本研究的所有病例和对照中,均使用限制性酶Stu1筛选了M98K多态性。结果:在2/18(11%)的高血压青光眼,0/9受试者(0%)的正常血压青光眼和3/94(3.2%)的对照组中发现了M98K风险相关改变。但是,对于高血压青光眼或正常血压青光眼,该变异与疾病的关联性均不显着(每种表型P = 0.2)。在一个患有开角型青光眼的受试者中发现了一种新颖的变体(外显子16中的P556P),并且在另一个具有开角型青光眼的受试者中和一个对照中发现了一种先前描述的变体(外显子7)。在本研究队列中未发现其他OPTN变体。结论:从BMES基线观察的横断面分析表明,与对照组相比,在高血压青光眼中,与M98K风险相关的等位基因的患病率更高,尽管这一发现没有统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号